395 related articles for article (PubMed ID: 17626403)
41. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
42. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
43. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer.
Nakagawa T; Negoro Y; Matsuoka T; Okumura N; Dodo Y
Respir Investig; 2014 Jul; 52(4):221-6. PubMed ID: 24998368
[TBL] [Abstract][Full Text] [Related]
45. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
Videtic GM; Stephans KL; Woody NM; Reddy CA; Zhuang T; Magnelli A; Djemil T
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):203-8. PubMed ID: 25015198
[TBL] [Abstract][Full Text] [Related]
46. Should aggressive surgery ever be part of the management of small cell lung cancer?
Waddell TK; Shepherd FA
Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer.
Scorsetti M; Navarria P; Facoetti A; Lattuada P; Urso G; Mirandola A; Ferraroli GM; Alloisio M; Ravasi G
Anticancer Res; 2007; 27(5B):3615-9. PubMed ID: 17972525
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies.
Onishi H; Araki T
Jpn J Clin Oncol; 2013 Apr; 43(4):345-50. PubMed ID: 23436937
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
Takeda A; Sanuki N; Eriguchi T; Kaneko T; Morita S; Handa H; Aoki Y; Oku Y; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):257-63. PubMed ID: 23570699
[TBL] [Abstract][Full Text] [Related]
50. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
[TBL] [Abstract][Full Text] [Related]
51. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?
Hoppe BS; Laser B; Kowalski AV; Fontenla SC; Pena-Greenberg E; Yorke ED; Lovelock DM; Hunt MA; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1283-6. PubMed ID: 19028267
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients.
Pennathur A; Luketich JD; Heron DE; Abbas G; Burton S; Chen M; Gooding WE; Ozhasoglu C; Landreneau RJ; Christie NA
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):597-604. PubMed ID: 19258073
[TBL] [Abstract][Full Text] [Related]
53. [Diagnosis and surgical treatment for stage I non-small-cell lung cancer].
Gao YS; Zhang DC; He J; Sun KL; Zhang DW; Zhang RG
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):52-5. PubMed ID: 15771801
[TBL] [Abstract][Full Text] [Related]
54. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
55. Treatment of stage I non-small cell lung cancer with CyberKnife, image-guided robotic stereotactic radiosurgery.
Ahn SH; Han MS; Yoon JH; Jeon SY; Kim CH; Yoo HJ; Lee JC
Oncol Rep; 2009 Mar; 21(3):693-6. PubMed ID: 19212628
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
58. SBRT effective for inoperable early-stage lung cancer.
Cancer Discov; 2014 Dec; 4(12):OF2. PubMed ID: 25477119
[TBL] [Abstract][Full Text] [Related]
59. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.
Kopek N; Paludan M; Petersen J; Hansen AT; Grau C; Høyer M
Radiother Oncol; 2009 Dec; 93(3):402-7. PubMed ID: 19559492
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.
Haasbeek CJ; Lagerwaard FJ; de Jaeger K; Slotman BJ; Senan S
Cancer; 2009 Feb; 115(3):587-94. PubMed ID: 19130457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
